HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
9.76 USD
-0.07 (-0.71%)
HLN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. HLN has an excellent profitability rating, but there are some minor concerns on its financial health. HLN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
HLN had positive earnings in the past year.
In the past year HLN had a positive cash flow from operations.
HLN had positive earnings in each of the past 5 years.
In the past 5 years HLN always reported a positive cash flow from operatings.
1.2 Ratios
HLN has a better Return On Assets (4.20%) than 85.34% of its industry peers.
With an excellent Return On Equity value of 8.92%, HLN belongs to the best of the industry, outperforming 84.29% of the companies in the same industry.
HLN's Return On Invested Capital of 6.11% is amongst the best of the industry. HLN outperforms 83.77% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HLN is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
With an excellent Profit Margin value of 12.84%, HLN belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
HLN's Profit Margin has improved in the last couple of years.
HLN has a Operating Margin of 21.31%. This is amongst the best in the industry. HLN outperforms 89.01% of its industry peers.
HLN's Operating Margin has improved in the last couple of years.
HLN has a better Gross Margin (60.75%) than 71.20% of its industry peers.
HLN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
HLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HLN has less shares outstanding
The number of shares outstanding for HLN has been reduced compared to 5 years ago.
The debt/assets ratio for HLN is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.29 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
HLN has a better Altman-Z score (2.29) than 61.26% of its industry peers.
The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 5.11, HLN belongs to the best of the industry, outperforming 82.20% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
HLN has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: HLN underperforms 64.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.29 |
ROIC/WACC0.71
WACC8.6%
2.3 Liquidity
A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
The Current ratio of HLN (0.98) is worse than 84.82% of its industry peers.
A Quick Ratio of 0.78 indicates that HLN may have some problems paying its short term obligations.
HLN has a worse Quick ratio (0.78) than 84.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.59% over the past year.
The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
HLN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.76% on average over the next years.
EPS Next Y5.7%
EPS Next 2Y8%
EPS Next 3Y8.66%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.92 indicates a rather expensive valuation of HLN.
Based on the Price/Earnings ratio, HLN is valued cheaply inside the industry as 81.15% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.55, HLN is valued a bit cheaper.
A Price/Forward Earnings ratio of 16.94 indicates a correct valuation of HLN.
Based on the Price/Forward Earnings ratio, HLN is valued a bit cheaper than the industry average as 79.06% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, HLN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.92 | ||
| Fwd PE | 16.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaper than 81.15% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 85.34% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.37 | ||
| EV/EBITDA | 14.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HLN may justify a higher PE ratio.
PEG (NY)3.5
PEG (5Y)1.13
EPS Next 2Y8%
EPS Next 3Y8.66%
5. Dividend
5.1 Amount
HLN has a Yearly Dividend Yield of 1.88%. Purely for dividend investing, there may be better candidates out there.
HLN's Dividend Yield is rather good when compared to the industry average which is at 0.52. HLN pays more dividend than 92.67% of the companies in the same industry.
HLN's Dividend Yield is comparable with the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
5.2 History
HLN has paid a dividend for at least 10 years, which is a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
HLN pays out 39.53% of its income as dividend. This is a sustainable payout ratio.
DP39.53%
EPS Next 2Y8%
EPS Next 3Y8.66%
NYSE:HLN (12/16/2025, 12:49:06 PM)
9.76
-0.07 (-0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap43.46B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.42 (17.01%)
Short Float %0.29%
Short Ratio1.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.09%
PT rev (3m)-3.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.27%
EPS NY rev (3m)0.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.92 | ||
| Fwd PE | 16.94 | ||
| P/S | 2.89 | ||
| P/FCF | 16.37 | ||
| P/OCF | 14.11 | ||
| P/B | 2.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.93 |
EPS(TTM)0.49
EY5.02%
EPS(NY)0.58
Fwd EY5.9%
FCF(TTM)0.6
FCFY6.11%
OCF(TTM)0.69
OCFY7.09%
SpS3.38
BVpS4.86
TBVpS-3.02
PEG (NY)3.5
PEG (5Y)1.13
Graham Number7.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.29 |
F-Score6
WACC8.6%
ROIC/WACC0.71
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.7%
EPS Next 2Y8%
EPS Next 3Y8.66%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.69%
EBIT Next 3Y8.39%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to HLN.
What is the valuation status for HLN stock?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HALEON PLC-ADR (HLN) stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 19.92 and the Price/Book (PB) ratio is 2.01.
How financially healthy is HALEON PLC-ADR?
The financial health rating of HALEON PLC-ADR (HLN) is 4 / 10.